Company: DVAX
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0001029142-25-000049
Chunk: 50

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-02-20
Form: 10-K
Item: Item 15
Chunk 50
---
 Exhibits 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9 and 3.10 above4.3Form of Specimen Common Stock Certificate4.2S-1/AJanuary 16, 2004333-1099654.4Indenture between Company and U.S. Bank National Association, as trustee, dated May 13, 20214.18-KMay 13, 2021001-342074.5Form of Global Note, representing Dynavax Technologies Corporation’s 2.5% Convertible Senior Notes due 2026 4.28-KMay 13, 2021001-342074.6Rights Agreement, dated as of October 28, 2024, between Company and Computershare Trust Company, N.A., which includes the form of Amended and Restated Certificate of Designation as Exhibit A and the form of Right Certificate as Exhibit B4.18-KOctober 29, 2024001-342074.7Amendment No. 1, dated as of December 26, 2024, to Rights Agreement, dated as of October 28, 2024, by and between Company and Computershare Trust Company, N.A., as Rights Agent4.18-KDecember 27, 2024001-3420710.1+Employment Agreement, dated July 12, 2013, by and between Robert Janssen, M.D. and Company10.8510-KMarch 10, 2014001-3420710.2+Chief Executive Officer Letter, dated December 13, 2019, between Company and Ryan Spencer 10.1710-KMarch 11, 2020001-3420710.3+President and Chief Operating Officer Letter, dated December 13, 2019, between Company and David Novack 10.1810-KMarch 11, 2020001-3420710.4+Offer Letter, dated December 14, 2020, by and between Company and Kelly MacDonald10.3310-KFebruary 25, 2021001-3420710.5+Offer Letter, dated May 26, 2021, by and between Company and John SlebirX10.6+Consulting Agreement, effective January 16, 2023, between Company and Peter